Organon & Co.
OGN
$13.31
-$0.02-0.15%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 246.00M | 187.00M | 501.00M | 700.00M | 750.00M |
| Total Depreciation and Amortization | 363.00M | 361.00M | 342.00M | 319.00M | 296.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 321.00M | 399.00M | 207.00M | 48.00M | 72.00M |
| Change in Net Operating Assets | -80.00M | -247.00M | -101.00M | -241.00M | -180.00M |
| Cash from Operations | 850.00M | 700.00M | 949.00M | 826.00M | 938.00M |
| Capital Expenditure | -167.00M | -162.00M | -172.00M | -168.00M | -161.00M |
| Sale of Property, Plant, and Equipment | 1.00M | 1.00M | 3.00M | 4.00M | 4.00M |
| Cash Acquisitions | 0.00 | -75.00M | -241.00M | -241.00M | -241.00M |
| Divestitures | 433.00M | -- | -- | -- | -- |
| Other Investing Activities | -99.00M | -154.00M | -211.00M | -176.00M | -191.00M |
| Cash from Investing | 168.00M | -390.00M | -621.00M | -581.00M | -589.00M |
| Total Debt Issued | 965.00M | 1.06B | 880.00M | 580.00M | 1.28B |
| Total Debt Repaid | -1.45B | -1.51B | -1.16B | -788.00M | -1.29B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -15.00M | -15.00M | -18.00M | -19.00M | -21.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -22.00M | -88.00M | -158.00M | -229.00M | -298.00M |
| Other Financing Activities | -- | -- | -2.00M | -2.00M | -38.00M |
| Cash from Financing | -524.00M | -561.00M | -456.00M | -458.00M | -369.00M |
| Foreign Exchange rate Adjustments | 75.00M | 150.00M | 37.00M | 108.00M | -8.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 569.00M | -101.00M | -91.00M | -105.00M | -28.00M |